Engineered nanomedicine for myeloma and bone microenvironment targeting
Bone is a favorable microenvironment for tumor growth and a frequent destination for metastatic cancer cells. Targeting cancers within the bone marrow remains a crucial oncologic challenge due to issues of drug availability and microenvironment-induced resistance. Herein, we engineered bone-homing p...
Main Authors: | Swami, Archana, Reagan, Michaela R., Basto, Pamela Antonia, Mishima, Yuji, Kamaly, Nazila, Glavey, Siobhan, Zhang, Sufeng, Moschetta, Michele, Seevaratnam, Dushanth, Zhang, Yong, Liu, Jinhe, Memarzadeh, Masoumeh, Manier, Salomon, Shi, Jinjun, Bertrand, Nicolas, Lu, Zhi Ning, Nagano, Kenichi, Baron, Roland, Sacco, Antonio, Roccaro, Aldo M., Farokhzad, Omid C., Ghobrial, Irene M., Wu, Jun, 1968- |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | en_US |
Published: |
National Academy of Sciences (U.S.)
2015
|
Online Access: | http://hdl.handle.net/1721.1/93754 https://orcid.org/0000-0002-9481-2258 |
Similar Items
-
Nanomedicines for endothelial disorders
by: Toth, Michael J., et al.
Published: (2018) -
Proteomic characterization of human multiple myeloma bone marrow extracellular matrix
by: Glavey, S V, et al.
Published: (2018) -
Nanomedicine in the management of microbial infection – Overview and perspectives
by: Zhu, Xi, et al.
Published: (2021) -
Nanomedicine in the management of microbial infection – Overview and perspectives
by: Zhu, Xi, et al.
Published: (2022) -
Nanomedicine /
by: Hutto, Madelynn, author 647998
Published: (2012)